Rare diseases
Investigational molecules
Locations
Back to Italy2 684 clinical trials in Novara, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on DMD06-MAB Injection for Duchenne Muscular Dystrophy in Non-Ambulant Patients
ItalyStudy on the Safety and Effectiveness of Etrumadenant, Quemliclustat, and Zimberelimab in Patients with Metastatic Colorectal Cancer
ItalyStudy on Gene Therapy with Atidarsagene Autotemcel for Patients with Metachromatic Leukodystrophy
ItalyStudy of Eribulin for Adults with Advanced Solitary Fibrous Tumor in Second or Third Line Treatment
ItalyStudy of NMD670 tablets to improve muscle strength in adults with TYPE 3 spinal muscular atrophy who can walk
ItalyStudy on Trastuzumab Deruxtecan and Drug Combination for Patients with High-Risk HER2-Positive Early Breast Cancer
ItalyStudy on Chlorambucil and Rituximab for Patients with MALT Lymphoma
ItalyStudy of Mosunetuzumab and Zanubrutinib for Patients with Relapsed or Refractory Follicular Lymphoma
ItalyStudy on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder
ItalyStudy on the Effectiveness of Fremanezumab for Preventing Migraines in Children and Teens Aged 6 to 17
ItalyStudy of Monalizumab for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Haploidentical Transplantation
ItalyStudy on the Effect of Cemiplimab in Patients with Oligometastatic Non-Small Cell Lung Cancer After Radical Treatment
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on hematologic malignancies and solid tumors, investigating innovative treatments for various cancer types including leukemia, breast cancer, and lung cancer.
Studies evaluating combination therapies and targeted treatments to improve patient outcomes.
Research focusing on heart failure prevention and treatment strategies, particularly exploring new drug combinations and their impact on cardiovascular outcomes.
Innovative approaches combining multiple therapeutic agents to address cardiovascular risks.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome and rheumatoid arthritis, with emphasis on novel therapeutic approaches.
Focus on developing targeted therapies for better disease management and patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
